NeuroWare is pleased to announce the launch of the NeuroWare Catalyst Fund, a flexible funding scheme designed to help researchers translate promising neuromorphic technologies from the laboratory towards real-world applications.
The fund will support a range of translational activities, from early-stage scoping and feasibility studies through to technology validation, and challenge-led projects. Funding is available through multiple award routes, with projects expected to demonstrate a clear pathway towards adoption, deployment, commercialisation or future investment.
Researchers interested in applying are encouraged to attend an applicant webinar on Thursday 17 September 2026 at 14:00 BST. The webinar will provide an overview of the scheme, funding routes and application process, and there will be an opportunity to ask questions. To register your interest in attending, please email info@neuroware-ikc.com.
